Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status

Karoly Szepeshazi, Andrew V. Schally, Gabor Halmos, Patricia Armatis, Francine Hebert, Baodong Sun, Anita Feil, Hippokratis Kiaris, Attila Nagy

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint Dive into the research topics of 'Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status'. Together they form a unique fingerprint.

Medicine & Life Sciences